This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Twi Biotechnology, Inc.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of Inventor Jing-Yi Lee
Introduction
Jing-Yi Lee, a prominent inventor based in Taipei, Taiwan, has made remarkable advances in the field of pharmaceutical technology. His expertise has led to the development of innovative solutions that contribute significantly to healthcare, particularly in the treatment of various diseases.
Latest Patents
Jing-Yi Lee holds a total of four patents, with his latest creations focusing on topical pharmaceutical formulations. One of his significant patents is for "Diacerein or rhein topical formulations and uses thereof," which provides a composition containing diacerein and its analogs aimed at treating several diseases. Additionally, he developed methods for inhibiting the expression of ASC and NLRP3, which are critical components in the formation of the NLRP3 inflammasome complex. His research includes methods and compositions for the treatment and prevention of disorders mediated by these components.
Career Highlights
Throughout his career, Jing-Yi Lee has been instrumental at Twi Biotechnology, Inc., where his innovative spirit and dedication to research have flourished. His focus on developing pharmaceutical compositions has positioned him as a key player in the biotechnology sector, contributing to advancements that improve patient outcomes.
Collaborations
Working alongside notable colleagues such as Chih-Kuang Chen and Wei-Shu Lu, Jing-Yi Lee has fostered a collaborative environment that enhances creativity and innovation. Together, they have combined their expertise to push the boundaries of current pharmaceutical practices, leading to groundbreaking inventions.
Conclusion
Jing-Yi Lee's inventive mind and dedication to his field have resulted in significant contributions to pharmaceutical science. His work not only exemplifies the spirit of innovation but also promises to enhance treatment options for patients battling various health conditions. His ongoing research at Twi Biotechnology, Inc. continues to inspire new developments in the realm of pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile